OUI Consulting Services: Enhancing the treatment of pain
The latest Nurofen Gender Pain Gap report reveals a widening gap between women and men in how pain is treated. Almost half of women feel their pain is ignored or dismissed by health professionals, while 14% of women surveyed still don’t have a diagnosis, compared with 9% of men.
These important insights are among the results of more than six years of close collaboration between Nurofen (Reckitt) and academic researchers, led by neuroscientist and pain expert Professor Rebeccah Slater of Oxford’s Department of Paediatrics.
Facilitated by OUI’s Consulting Services team, this collaborative work has informed some of Reckitt’s most impactful public health campaigns – not least the company’s drive to highlight women’s experiences of pain – and has helped drive change in the management of pain.
The collaboration has also resulted in the formation of multiple OUI-led advisory boards, a series of academic papers and reports, two industry-sponsored DPhil students at Oxford, and clinical studies that consider the effectiveness of pain treatments.
We are so grateful to Professor Rebeccah Slater and her team for adding enormous value to our work on Nurofen, ensuring our pain brands are backed by the best insights, the best evidence and the best science. The Oxford-Reckitt partnership shows what can be achieved through academic-industry collaboration, making a real difference to people in pain – and the work on the gender pain gap is a shining example of that.
OUI activities
- Communication & marketing
- IP identification and protection
- Licensing & contracts
